8365 Results
1

Advances made in UC research extending lives

October 17, 2022

Treatments for pulmonary arterial hypertension (PAH) — a type of high blood pressure that affects arteries in the lungs and in the heart — have improved significantly over the past 15 to 20 years and researchers at the University of Cincinnati have been at the forefront of those improvements. The result of a series of studies UC researchers were part of have allowed new medications to come to market for patients with PAH.

3

UC researcher joins pediatric immunotherapy network

October 19, 2023

The University of Cincinnati’s Timothy Phoenix is one of the investigators on a research team that is part of a new NCI Pediatric Immunotherapy Network and studying how to improve immunotherapy treatments for pediatric brain tumors.

4

UC study identifies molecule that could improve asthma treatments

January 29, 2024

Researchers are passionate about their fields of study for a variety of reasons. For Satish Madala, his focus on asthma is deeply personal. “This is my ‘close to heart’ project because I came to this research area mainly because of my childhood asthma,” says Madala, PhD, of the UC College of Medicine.

6

UC launches Cincy BEARCAT study

September 16, 2022

The Cincy BEARCAT study aims to learn more about the causes of cardiac arrest. The just-launched study will create a biorepository of blood samples that can be used in this project as well as future research. The hypothesis is that there is a lot of diversity in cardiac arrest patients as far as the cause of the cardiac arrest.

8

UC research sees decrease in emergency visits for stroke care

July 9, 2020

Immediately following the announcement of COVID-19 prevention measures in March, the Greater Cincinnati Tristate region saw a nearly 40% decline in patients coming to the hospital in time for emergency stroke care, according to researchers from the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital Medical Center. The researchers are calling for urgent public education to mitigate a potential crisis of stroke patients avoiding needed emergency care due to concerns about COVID-19

9

UC researcher examines genetic role in addiction

October 12, 2020

In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits. Pharmacogenomics, a relatively new field, is the study of how genes affect a person's response to drugs.